Amedisys, Inc. (NASDAQ:AMED) Shares Sold by GABELLI & Co INVESTMENT ADVISERS INC.

GABELLI & Co INVESTMENT ADVISERS INC. decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 192,445 shares of the health services provider's stock after selling 8,236 shares during the quarter. Amedisys makes up about 3.0% of GABELLI & Co INVESTMENT ADVISERS INC.'s holdings, making the stock its 7th largest position. GABELLI & Co INVESTMENT ADVISERS INC. owned 0.59% of Amedisys worth $17,472,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Blue Trust Inc. increased its stake in Amedisys by 55.1% in the fourth quarter. Blue Trust Inc. now owns 349 shares of the health services provider's stock valued at $34,000 after purchasing an additional 124 shares during the period. Xponance Inc. grew its holdings in shares of Amedisys by 3.5% during the fourth quarter. Xponance Inc. now owns 4,349 shares of the health services provider's stock worth $395,000 after buying an additional 148 shares during the last quarter. Inspire Investing LLC increased its position in Amedisys by 3.6% in the 4th quarter. Inspire Investing LLC now owns 4,405 shares of the health services provider's stock valued at $400,000 after acquiring an additional 155 shares during the period. Gamco Investors INC. ET AL raised its stake in Amedisys by 0.5% during the 4th quarter. Gamco Investors INC. ET AL now owns 30,334 shares of the health services provider's stock valued at $2,754,000 after acquiring an additional 159 shares during the last quarter. Finally, Nisa Investment Advisors LLC lifted its position in Amedisys by 1.2% during the 4th quarter. Nisa Investment Advisors LLC now owns 15,150 shares of the health services provider's stock worth $1,375,000 after acquiring an additional 180 shares during the period. 94.36% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently issued reports on AMED. Stephens reissued an "equal weight" rating and issued a $101.00 target price on shares of Amedisys in a report on Tuesday, March 4th. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research note on Wednesday. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, Amedisys has an average rating of "Hold" and a consensus target price of $100.75.

Amedisys Price Performance

Shares of AMED traded down $0.15 during mid-day trading on Friday, hitting $91.76. The company's stock had a trading volume of 133,860 shares, compared to its average volume of 400,397. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. Amedisys, Inc. has a 1-year low of $82.15 and a 1-year high of $98.95. The firm has a market capitalization of $3.01 billion, a P/E ratio of 36.41, a P/E/G ratio of 1.78 and a beta of 0.89. The firm has a 50-day simple moving average of $92.14 and a 200 day simple moving average of $91.89.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported $0.96 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $598.05 million during the quarter, compared to analyst estimates of $602.38 million. Analysts predict that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.